Sanofi will offer its first batch of COVID-19 vaccine to the U.S.
Category: #health  By Saipriya Iyer  Date: 2020-05-14
  • share
  • Twitter
  • Facebook
  • LinkedIn

Sanofi will offer its first batch of COVID-19 vaccine to the U.S.

The company has collaborated with GlaxoSmithKline Plc to conduct this vaccine development project.

French pharmaceutical giant, Sanofi has been making tremendous advancements in COVID-19 vaccine development. Recently, the biotech made a groundbreaking announcement as it revealed that the U.S. would get its first COVID-19 vaccine, if it manages to successfully deliver one.

According to Sanofi’s Chief Executive Officer, Paul Hudson, the decision is made because the U.S. was first in line to back their company’s vaccine research. Hudson warned that Europe is at the risk of falling behind until it accelerates its efforts to combat against this devastating pandemic that has almost killed over 290,000 people across the globe.

He added that the U.S. government has earned the right to obtain the biggest batch of pre-order due to its constant support to Sanofi. The U.S. had expanded its vaccine partnership in February with the company and it expects to receive the doses first, which it had helped it manufacture.

For the record. Sanofi is one of the largest firms seeking an effective vaccine for this health crisis. It has collaborated with U.K.’s GlaxoSmithKline Plc to conduct this drug development project. In fact, the company aims to produce almost 600 million doses yearly once it successfully accomplishes this project.

Various governments have launched multiple research efforts and funding drives to develop a new vaccine for this virus. However, numerous health advocates are concerned that this race of funding could leave out those nations that aren’t able to afford protective doses, making them vulnerable to economic wreckage and mass fatalities.

In other news, Sanofi has managed to bag an approval from the U.S. Food & Drug Administration (FDA) for its sutimlimab product. Reportedly, this drug focuses on treating hemolysis in adults going through cold agglutinin disease.

Source Credit: https://theprint.in/world/us-will-get-sanofis-coronavirus-vaccine-first-if-the-drug-giants-efforts-succeed/421000/



About Author

Saipriya Iyer

Email: [email protected]   

Saipriya Iyer

Saipriya Iyer develops content for Market Size Forecasters, Algosonline, and myriad other platforms. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her bel...

Read More

More News By Saipriya Iyer

AdaptHealth enters definitive deals to acquire Solara & ActivStyle
AdaptHealth enters definitive deals to acquire Solara & ActivStyle
By Saipriya Iyer

AdaptHealth Corp. has recently entered two separate definitive agreements for the acquisition of Solara Medical Supplies, LLC and ActivStyle, Inc. AdaptHealth is a leading home medical supplies, equipment, and other re...

Ambani’s JioMart unveils a new website to deliver orders across India
Ambani’s JioMart unveils a new website to deliver orders across India
By Saipriya Iyer

Jio Platforms, the top telecom operator along with Jio Retail, which is the top retail chain has recently unveiled JioMart’s new website and has begun taking orders in a large amount from tier 1, tier 2 and metro c...

Omada enters $30M acquisition deal with digital health company Physera
Omada enters $30M acquisition deal with digital health company Physera
By Saipriya Iyer

Omada Health, which has raised nearly $57 million in funding, has reportedly acquired a digital health company, Physera. It provides remote physical therapy to its customers.

The co...